Consumers seeking out products to help them stay healthy during the COVID-19 pandemic provided a tailwind for Nestlé Health Science in 2020, with sales at the business up double digits over the 12 months.
Nestlé Health Science posted turnover up 12% to CHF3.3bn ($3.7bn) in 2020, which the firm said reflected higher demand for...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?